5th Pharmacovigilance Congregation 2013 is a conference that covers topics such as: controversies and complexities in pharmacovigilance and risk management throughout all phases of drug development, including:
- Keeping abreast of the changes impacting the drug safety industry to ensure the pharmacovigilance strategies are robust and geared to compliance
- Exploiting the latest technologies, methodologies & automations on work practices of Pharmacovigilance
- How will PV activities change with Clinical Trial Transformation Initiative?
- Recent successful strategies and business models to bring out new medicines
- Exploiting the pharmacy automations and technologies for enhancement of medication safety
- Identifying essential antidote requirements and learn to implement best practices in drug safety and surveillance
- Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
- Stay ahead of computing and electronic communications in pharmacovigilance
- Determining the steps and strategies for enhancing quality in healthcare
- Establishing the importance of pharmacovigilance for the safety of the patient
- Analyzing the information on current industry projects and trends
- Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
- Global marketing strategies in order to engage with regulatory centres of excellence on pharmacovigilance
- Identifying the latest regulatory framework for pharmacovigilance
- Explaining how to use the data sources and observational research for effective safety analysis
- Accelerating new medicine introduction in developing world & overcoming challenges
- Be part of a major networking opportunity
- Good supply chain management practices for medicine distribution
5th Pharmacovigilance Congregation 2013 brings together pharmaceutical, biotech, and regulatory representatives.
